-
1
-
-
38949187920
-
Pharmacologic treatment of ADHD: Road conditions in driving patients to successful outcomes
-
Manos MJ. Pharmacologic treatment of ADHD: road conditions in driving patients to successful outcomes. Medscape J Med 2008;8:10:5
-
(2008)
Medscape J Med
, vol.8
, Issue.10
, pp. 5
-
-
Manos, M.J.1
-
2
-
-
0034963296
-
Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder
-
DOI 10.1542/peds.108.1.71
-
Guevara J, Lozano P, Wickizer T, et al. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics 2001;108:71-8 (Pubitemid 32592007)
-
(2001)
Pediatrics
, vol.108
, Issue.1
, pp. 71-78
-
-
Guevara, J.1
Lozano, P.2
Wickizer, T.3
Mell, L.4
Gephart, H.5
-
3
-
-
85035146867
-
The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication
-
DOI 10.1176/appi.ajp.163.4.716
-
Kessler R, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 2006;163:716-23 (Pubitemid 44464584)
-
(2006)
American Journal of Psychiatry
, vol.163
, Issue.4
, pp. 716-723
-
-
Kessler, R.C.1
Adler, L.2
Berkley, R.3
Biederman, J.4
Conners, C.K.5
Demler, O.6
Faraone, S.V.7
Greenhill, L.L.8
Howes, M.J.9
Secnik, K.10
Spencer, T.11
Ustun, T.B.12
Walters, E.E.13
Zaslavsky, A.M.14
-
4
-
-
79957692249
-
Risk of injury associated with attention-deficit/hyperactivity disorder in adults enrolled in employer-sponsored health plans
-
Hodgkins P, Montejano L Sasané R, et al. Risk of injury associated with attention-deficit/hyperactivity disorder in adults enrolled in employer-sponsored health plans. Primary Care Companion 2011;13:e1-e12
-
(2011)
Primary Care Companion
, vol.13
-
-
Hodgkins, P.1
Montejano, L.2
Sasané, R.3
-
5
-
-
1642514265
-
The worldwide prevalence of ADHD: Is it an American condition?
-
Faraone SV, Sergeant J, Gillberg C, et al. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2003;2:104-13
-
(2003)
World Psychiatry
, vol.2
, pp. 104-113
-
-
Faraone, S.V.1
Sergeant, J.2
Gillberg, C.3
-
6
-
-
22144455050
-
Attention-deficit hyperactivity disorder
-
DOI 10.1016/S0140-6736(05)66915-2, PII S0140673605669152
-
Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005;366:237-48 (Pubitemid 40981053)
-
(2005)
Lancet
, vol.366
, Issue.9481
, pp. 237-248
-
-
Biederman, J.1
Faraone, S.V.2
-
7
-
-
37548998944
-
Predictors of diagnostic delay in a clinical sample of French children with attention-deficit/hyperactivity disorder
-
Purper-Ouakil D, Cortese S, Wohl M, et al. Predictors of diagnostic delay in a clinical sample of French children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry 2007;16:505-9
-
(2007)
Eur Child Adolesc Psychiatry
, vol.16
, pp. 505-509
-
-
Purper-Ouakil, D.1
Cortese, S.2
Wohl, M.3
-
8
-
-
33746635186
-
Long-term stimulant medication treatment of attention-deficit/ hyperactivity disorder: Results from a population-based study
-
DOI 10.1097/00004703-200602000-00001, PII 0000470320060200000001
-
Barbaresi WJ, Katusic SK, Colligan RC, et al. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a populationbased study. J Dev Behav Pediatr 2006;27:1-10 (Pubitemid 44315107)
-
(2006)
Journal of Developmental and Behavioral Pediatrics
, vol.27
, Issue.1
, pp. 1-10
-
-
Barbaresi, W.J.1
Katusic, S.K.2
Colligan, R.C.3
Weaver, A.L.4
Leibson, C.L.5
Jacobsen, S.J.6
-
9
-
-
54249133889
-
Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic achievement
-
Powers RL, Marks DJ, Miller CJ, et al. Stimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic achievement. J Child Adolesc Psychopharmacol 2008;18:449-59
-
(2008)
J Child Adolesc Psychopharmacol
, vol.18
, pp. 449-459
-
-
Powers, R.L.1
Marks, D.J.2
Miller, C.J.3
-
10
-
-
66049093064
-
Positive association between attention-deficit/hyperactivity disorder medication use and academic achievement during elementary school
-
Scheffler RM, Brown TT, Fulton BD, et al. Positive association between attention-deficit/hyperactivity disorder medication use and academic achievement during elementary school. Pediatrics 2009;123:1273-9
-
(2009)
Pediatrics
, vol.123
, pp. 1273-1279
-
-
Scheffler, R.M.1
Brown, T.T.2
Fulton, B.D.3
-
11
-
-
3042622074
-
Clinical practice guideline: Treatment of the school-age child with attention-deficit/hyperactivity disorder
-
American Academy of Pediatrics
-
American Academy of Pediatrics. Clinical practice guideline: treatment of the school-age child with attention-deficit/hyperactivity disorder. Pediatrics 2001;4:1033-44
-
(2001)
Pediatrics
, vol.4
, pp. 1033-1044
-
-
-
12
-
-
70350768832
-
-
Canadian Attention Deficit Hyperactivity Disorder Resource Alliance [CADDRA] [Last accessed November 2009]
-
Canadian Attention Deficit Hyperactivity Disorder Resource Alliance [CADDRA]. Canadian ADHD Practice Guidelines. Available at: http://www.caddra.ca/ cms4/index.php?optioncom-content&viewarticle&id 26&Itemid353& langen [Last accessed November 2009]
-
Canadian ADHD Practice Guidelines
-
-
-
13
-
-
52649104413
-
Diagnosis and management of attentiondeficit/hyperactivity disorder in children, young people, adults: Summary of NICE guidance
-
Kendall T, Taylor E, Perez A, et al. Diagnosis and management of attentiondeficit/hyperactivity disorder in children, young people, adults: summary of NICE guidance. BMJ 2008;337:a1239
-
(2008)
BMJ
, vol.337
-
-
Kendall, T.1
Taylor, E.2
Perez, A.3
-
14
-
-
34250797891
-
Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder
-
AACAP Work Group on Quality Issues
-
Pliszka S, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2007;46:894-21
-
(2007)
J Am Acad Child Adolesc Psychiatry
, vol.46
, pp. 894-821
-
-
Pliszka, S.1
-
15
-
-
27744601191
-
Treatment of attention-deficit/hyperactivity disorder: Overview of the evidence
-
DOI 10.1542/peds.2004-2560
-
Brown RT, Amler RW, Freeman WS, et al.; American Academy of Pediatrics Committee on Quality Improvement. American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder. Treatment of attention-deficit/ hyperactivity disorder: overview of the evidence. Pediatrics 2005;115:e749-e757 (Pubitemid 43843150)
-
(2005)
Pediatrics
, vol.115
, Issue.6
-
-
Brown, R.T.1
Amler, R.W.2
Freeman, W.S.3
Perrin, J.M.4
Stein, M.T.5
Feldman, H.M.6
Pierce, K.7
Wolraich, M.L.8
-
16
-
-
70449120823
-
Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder
-
Spencer TJ, Greenbaum M, Ginsberg LD, et al. Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2009;19:501-10
-
(2009)
J Child Adolesc Psychopharmacol
, vol.19
, pp. 501-510
-
-
Spencer, T.J.1
Greenbaum, M.2
Ginsberg, L.D.3
-
17
-
-
78651479969
-
Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder
-
Jair R, Segal S, Kollins SH, et al. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2011;50:171-9
-
(2011)
J Am Acad Child Adolesc Psychiatry
, vol.50
, pp. 171-179
-
-
Jair, R.1
Segal, S.2
Kollins, S.H.3
-
18
-
-
77950350304
-
The quality of life of children with attention deficit/hyperactivity disorder: A systematic review
-
Danckaerts M, Sonuga-Barke EJ, Banaschewski T, et al. The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry 2010;19:83-105
-
(2010)
Eur Child Adolesc Psychiatry
, vol.19
, pp. 83-105
-
-
Danckaerts, M.1
Sonuga-Barke, E.J.2
Banaschewski, T.3
-
19
-
-
33748656471
-
Effectiveness outcomes in attentiondeficit/hyperactivity disorder
-
Weiss MD, Gadow K, Wasdell MB, et al. Effectiveness outcomes in attentiondeficit/hyperactivity disorder. J Clin Psychiatry 2006;67(Suppl 8):38-45
-
(2006)
J Clin Psychiatry
, vol.67
, Issue.SUPPL. 8
, pp. 38-45
-
-
Weiss, M.D.1
Gadow, K.2
Wasdell, M.B.3
-
20
-
-
70349285147
-
The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness
-
Velligan DI, Weiden PJ, Sajatovic M, et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J Clin Psychiatry 2009;70(Suppl 4):1-46
-
(2009)
J Clin Psychiatry
, vol.70
, Issue.SUPPL. 4
, pp. 1-46
-
-
Velligan, D.I.1
Weiden, P.J.2
Sajatovic, M.3
-
21
-
-
3242749792
-
Satisfaction with treatment for attention-deficit/hyperactivity disorder
-
Buckstein OG. Satisfaction with treatment for attention-deficit/ hyperactivity disorder. Am J Manag Care 2004;10:S107-16
-
(2004)
Am J Manag Care
, vol.10
-
-
Buckstein, O.G.1
-
22
-
-
73249133383
-
Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?
-
Buckstein OG, Arnold LE, Landgraf JM, et al. Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder? Child Adolesc Psych Mental Health 2009;2:39
-
(2009)
Child Adolesc Psych Mental Health
, vol.2
, pp. 39
-
-
Buckstein, O.G.1
Arnold, L.E.2
Landgraf, J.M.3
-
23
-
-
77958551382
-
Time course and predictors of healthrelated quality of life improvement and medication satisfaction in children diagnosed with attention-deficit/ hyperactivity disorder treatment with the methylphenidate transdermal system
-
Frazier TW, Weiss M, Hodgkins P, et al. Time course and predictors of healthrelated quality of life improvement and medication satisfaction in children diagnosed with attention-deficit/hyperactivity disorder treatment with the methylphenidate transdermal system. J Child Adolesc Psychopharmacol 2010;20:355-64
-
(2010)
J Child Adolesc Psychopharmacol
, vol.20
, pp. 355-364
-
-
Frazier, T.W.1
Weiss, M.2
Hodgkins, P.3
-
24
-
-
72549111730
-
HRQL and medication satisfaction in children with ADHD treatment with the methylphenidate transdermal system
-
Manos M, Frazier TW, Landgraf JM, et al. HRQL and medication satisfaction in children with ADHD treatment with the methylphenidate transdermal system. CMRO 2009;25:3001-10
-
(2009)
CMRO
, vol.25
, pp. 3001-3010
-
-
Manos, M.1
Frazier, T.W.2
Landgraf, J.M.3
-
25
-
-
77951081496
-
Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder
-
Weiss MD, Gibbins C, Goodman DW, et al. Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder. J Clin Psych 2010;71:381-90
-
(2010)
J Clin Psych
, vol.71
, pp. 381-390
-
-
Weiss, M.D.1
Gibbins, C.2
Goodman, D.W.3
-
26
-
-
84884350750
-
Attention deficit hyperactivity disorder
-
National Institute for Health and Clinical Excellence NICE [Last accessed 22 Sep 2011]
-
National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder. NICE clinical guideline 72. NICE, 2008. Available at: http://guidance.nice.org.uk/CG72/NICEGuidance/pdf/English [Last accessed 22 Sep 2011]
-
(2008)
NICE Clinical Guideline 72
-
-
-
27
-
-
33845794758
-
Study design, baseline patient characteristics and intervention in a cross-cultural framework: Results from the ADORE study
-
ADORE Study Group
-
Preuss U, Ralston SJ, Baldursson G, et al. ADORE Study Group. Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study. Eur Child Adolesc Psychiatry 2006;15(Suppl 1):14-14
-
(2006)
Eur Child Adolesc Psychiatry
, vol.15
, Issue.SUPPL. 1
, pp. 14-14
-
-
Preuss, U.1
Ralston, S.J.2
Baldursson, G.3
-
28
-
-
34548023694
-
The economic impact of attention-deficit/hyperactivity disorder in children and adolescents
-
DOI 10.1093/jpepsy/jsm022
-
Pelham WE, Foster EM, Robb JA. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. J Pediatr Psychol 2007;32:711-27 (Pubitemid 47356048)
-
(2007)
Journal of Pediatric Psychology
, vol.32
, Issue.6
, pp. 711-727
-
-
Pelham, W.E.1
Foster, E.M.2
Robb, J.A.3
-
29
-
-
77949497812
-
Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: Retrospective claims-based analysis of a managed care population
-
Christensen L, Sasané R, Hodgkins P, et al. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin 2010;26:977-89
-
(2010)
Curr Med Res Opin
, vol.26
, pp. 977-989
-
-
Christensen, L.1
Sasané, R.2
Hodgkins, P.3
-
30
-
-
0031427407
-
Variations in compliance among hypertensive patients by drug class: Implications for health care costs
-
DOI 10.1016/S0149-2918(97)80018-5
-
Rizzo JA, Simons WR. Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther 1997;19:1446-57 (Pubitemid 28133280)
-
(1997)
Clinical Therapeutics
, vol.19
, Issue.6
, pp. 1446-1457
-
-
Rizzo, J.A.1
Simons, W.R.2
-
31
-
-
0025282371
-
Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation
-
Barkley RA, McMurray MB, Edelbrock CS, et al. Side effects of methylphenidate in children with attention deficit hyperactivity disorder. A systematic, placebo-controlled evaluation. Paediatrics 1990;86:184-92 (Pubitemid 20238848)
-
(1990)
Pediatrics
, vol.86
, Issue.2
, pp. 184-192
-
-
Barkley, R.A.1
McMurray, M.B.2
Edelbrock, C.S.3
Robbins, K.4
-
32
-
-
0036832631
-
Efficacy of a New Pattern of Delivery of Methylphenidate for the Treatment of ADHD: Effects on Activity Level in the Classroom and on the Playground
-
DOI 10.1097/00004583-200211000-00011
-
Swanson JM, Gupta S, Williams L, et al. Efficacy of a new pattern of delivery of methylphenidate for the treatment of ADHD: effects on activity level in the classroom and on the playground. J Am Acad Child Adolesc Psychiatry 2002;41:1306-14 (Pubitemid 38338021)
-
(2002)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.41
, Issue.11
, pp. 1306-1314
-
-
Swanson, J.M.1
Gupta, S.2
Williams, L.3
Agler, D.4
Lerner, M.5
Wigal, S.6
-
33
-
-
4444352968
-
European clinical guidelines for hyperkinetic disorder-first upgrade
-
Taylor E, Dopfner M, Sergeant J, et al. European clinical guidelines for hyperkinetic disorder-first upgrade. Eur Child Adolesc Psychiatry 2004;13(Suppl 1):17-30
-
(2004)
Eur Child Adolesc Psychiatry
, vol.13
, Issue.SUPPL. 1
, pp. 17-30
-
-
Taylor, E.1
Dopfner, M.2
Sergeant, J.3
-
35
-
-
0035141471
-
Methylphenidate dosage for children with ADHD over time under controlled conditions: Lessons from the MTA
-
Vitiello B, Severe JB, Greenhill LL, et al. Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA. J Am Acad Child Adolesc Psychiatry 2001;40:188-96 (Pubitemid 32111022)
-
(2001)
Journal of the American Academy of Child and Adolescent Psychiatry
, vol.40
, Issue.2
, pp. 188-196
-
-
Vitiello, B.1
Severe, J.B.2
Greenhill, L.L.3
Arnold, L.E.4
Abikoff, H.B.5
Bukstein, O.G.6
Elliott, G.R.7
Hechtman, L.8
Jensen, P.S.9
Hinshaw, S.P.10
March, J.S.11
Newcorn, J.H.12
Swanson, J.M.13
Cantwell, D.P.14
-
36
-
-
35848947225
-
Effectiveness of methylphenidate in the 10-month continuation phase of the preschoolers with attention-deficit/hyperactivity disorder treatment study (PATS)
-
Vitiello B, Abikoff HB, Chuang SZ, et al. Effectiveness of methylphenidate in the 10-month continuation phase of the preschoolers with attention-deficit/hyperactivity disorder treatment study (PATS). J Child Adolesc Psychopharmcol 2007;17:593-604
-
(2007)
J Child Adolesc Psychopharmcol
, vol.17
, pp. 593-604
-
-
Vitiello, B.1
Abikoff, H.B.2
Chuang, S.Z.3
-
37
-
-
2342599689
-
Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder
-
Perwein AR, Hall J, Swensen A, et al. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/ hyperactivity disorder. JMCP 2004;10:122-9
-
(2004)
JMCP
, vol.10
, pp. 122-129
-
-
Perwein, A.R.1
Hall, J.2
Swensen, A.3
-
38
-
-
67650308856
-
Medication adherence in the MTA: Saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment
-
Pappadopulos E, Jensen PS, Chait AR, et al. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment. J Am Acad Child Adolesc Psychiatry 2009;48:501-10
-
(2009)
J Am Acad Child Adolesc Psychiatry
, vol.48
, pp. 501-510
-
-
Pappadopulos, E.1
Jensen, P.S.2
Chait, A.R.3
-
39
-
-
21444440571
-
Assessment of adherence measures with different stimulants among children and adolescents
-
DOI 10.1592/phco.2005.25.7.909
-
Sanchez RJ, Crismon ML, Barner JC, et al. Assessment of adherence measures with difference stimulants among children and adolescents. Pharmacotherapy 2005;25:909-17 (Pubitemid 40917923)
-
(2005)
Pharmacotherapy
, vol.25
, Issue.7
, pp. 909-917
-
-
Sanchez, R.J.1
Crismon, M.L.2
Barner, J.C.3
Bettinger, T.4
Wilson, J.P.5
-
40
-
-
0035676124
-
Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors
-
DOI 10.1192/bjp.179.6.519
-
Meijer WE, Bouvy ML, Heerdink ER, et al. Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors. Br J Psychiatry 2001;179:519-22 (Pubitemid 34031677)
-
(2001)
British Journal of Psychiatry
, vol.179
, Issue.DEC.
, pp. 519-522
-
-
Meijer, W.E.E.1
Bouvy, M.L.2
Heerdink, E.R.3
Urquhart, J.4
Leufkens, H.G.M.5
-
41
-
-
0033950999
-
Predicting medication noncompliance after hospital discharge among patients with schizophrenia
-
DOI 10.1176/appi.ps.51.2.216
-
Olfson M, Mechanic D, Hansell S, et al. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv 2000;51:216-22 (Pubitemid 30082525)
-
(2000)
Psychiatric Services
, vol.51
, Issue.2
, pp. 216-222
-
-
Olfson, M.1
Mechanic, D.2
Hansell, S.3
Boyer, C.A.4
Walkup, J.5
Weiden, P.J.6
-
42
-
-
0000822363
-
Methylphenidate vs. amphetamine: Comparative review
-
Arnold LE. Methylphenidate vs. amphetamine: comparative review. J Attention Disord 2000;4:200-11
-
(2000)
J Attention Disord
, vol.4
, pp. 200-211
-
-
Arnold, L.E.1
-
43
-
-
0036080212
-
Efficacy of adderall and methylphenidate in attention deficit hyperactivity disorder: A drug-placebo and drug-drug response curve analysis of a naturalistic study
-
DOI 10.1017/S1461145702002845
-
Faraone SV, Short EJ, Biederman J, et al. Efficacy of Adderall and methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study. Int J Neuropsychopharmacol 2002;5:121-9 (Pubitemid 34662974)
-
(2002)
International Journal of Neuropsychopharmacology
, vol.5
, Issue.2
, pp. 121-129
-
-
Faraone, S.V.1
Short, E.J.2
Biederman, J.3
Findling, R.L.4
Roe, C.5
Manos, M.J.6
|